Broadcast journalist says the results are dramatic By Cheche V. Moral Philippine Daily Inquirer

DAVILA and her firstborn David at age 10

You can point a mother to the ends of the earth and it wont weaken her resolve to find that cure for her ailing child.

Broadcast journalist Karen Davilas firstborn, David, was 3 years old when he was diagnosed with Pervasive Developmental Disorder, Not Otherwise Specified (PDD/NOS) in the Autism Spectrum, a severe form of autism. The development pediatrician said there was no cure for Davids condition.

David didnt have the classic signs of autism, but clearly he wasnt developing like other children his age, says Davila. At the age of 3, he wasnt speaking spontaneously, although he could read. He had tantrums, couldnt express his needs, whether he was hungry or sad, and didnt reach out to other children his age.

Like most kids in the autism spectrum, the boy had attention difficulties. He was spaced out most of the time, and was rigid. It was so heartbreaking to see my eldest this way, she adds.

Davila refused to accept that there was no answer to her sons condition. I researched endlessly and devoted myself to making sure my son got the best possible treatment, she says. She quickly put her son on a casein- and gluten-free diet and biomedical treatment, under the care of Defeat Autism Now (DAN)-licensed doctors.

Davila explains that kids like David lack an enzyme in the body to digest casein, a protein found in cows milk, and gluten, a protein found in wheat, oats, barley and rye. When they take [casein and gluten], it feels like opium in the body, so kids feel high, theyre so hyper, get wild and are spaced out.

David, now 11, has also undergone anti-fungal treatments, and has been taking supplements and B12 injections to help his attention issues. He has also benefited from the help of occupational and speech therapists. Now in Grade 5, David is in his grade level in Multiple Intelligence School, in a smaller class ratio, according to his mother.

Early last year, Davila was offered an opportunity to try the fresh cell therapy being offered by a clinic in Germany called Villa Medica. The stem cells are harvested from lamb fetus and injected into the patient. By then, the journalist-mom had read up on the supposed benefits of stem cell on children with special needs.

Continued here:
Karen Davila resorts to stem-cell therapy for son’s autism

Published on 10 January 2013 Hits: 937 Written by Jovee Marie N. Dela Cruz

A HEALTH expert on Wednesday warned that stem cell therapy can also kill.

Dr. Leo Olarte, spokesman of the Philippine Society for Stem Cell Medicine, said that if the stem cell that a patient received is from a donor, it could lead to fatal complications.

He said that a stem cell transplant can pose risks of complications, some potentially fatal, depending on many factors including the type of blood disorder, the type of transplant and the age and health of the person.

Although some people experience few problems with a transplant, others may develop complications that may require treatment or hospitalization. Some complications could even be life-threatening, warned Olarte, also the vice chairman of the Philippine Medical Association.

He said that such complications could be in the form of graft-versus-host disease (allogeneic transplant only), stem cell (graft) failure, organ injury, infections, cataracts, infertility, new cancers and even death.

Olarte said that anyone undergoing a transplant using stem cells from a donor (allogeneic stem cell transplant) may be at risk of graft-versus-host disease.

This condition occurs when a donors transplanted stem cells attack your body. Graft-versus-host disease can be mild or severe. It can occur soon after your transplant or months to years later, he added.

The doctor said that incompatibility can also lead to diseases of the skin (rash, often like sunburn), gut (mouth sores, abdominal pain, diarrhea, nausea or vomiting), liver (jaundice or yellowing of the skin), lungs (blocked airways) or eyes (irritation and light sensitivity).

It can lead to chronic disability due to organ injury or infections and can be life-threatening. Your doctor must monitor closely for signs and symptoms of graft-versus-host disease, Olarte said.

Read the original:
Stem cell therapy can kill – health expert

Pioneers Stem Cell Therapy Poland veterinary dogs orthopedics, neurology, nefrology.wmv
Lubelskie Centrum Ma #322;ych Zwierz #261;t Using 10 years of knowledge in small animal Stem Cell Therapy in USA from one of the leading Referral Specialists Veterinary Clinic Pioneers of Stem Cell Therapy in Nefrology (with hemodialysis units) Orthopedics Neurology in Poland Any contact at komorkimacierzyste@lcmz.pl Each case is treated individually in terms of stem cell therapy. If there is any contraindication to the use of the therapy it wont be given.

By: MrLCMZ

See the rest here:
Pioneers Stem Cell Therapy Poland veterinary dogs orthopedics, neurology, nefrology.wmv - Video

Stemlogix Stem Cell therapy at Central Animal Hospital St Petersburg Florida
Central Animal Hospital of St Petersburg, FL now offers in house Stemlogix Stem Cell Therapy for osteoarthritis for dogs! More info: http://www.centralanimal.net or http://www.tbk9rehab.com

By: StemLogixLLC

Read the rest here:
Stemlogix Stem Cell therapy at Central Animal Hospital St Petersburg Florida - Video

Public release date: 11-Feb-2013 [ | E-mail | Share ]

Contact: Megan McCann memccann@nmh.org 312-926-5900 Northwestern Memorial Hospital

Each year, nearly 800,000 Americans suffer a stroke which can result in permanent brain damage, long term disability or death. As a leading cause of adult disability, stroke has an annual burden of more than $62 billion on the United States economy. With the exception of rehabilitation therapy, very few treatments are available to improve the chronic neurologic deficits caused by a stroke. In hopes of expanding therapeutic options, Northwestern Medicine researchers are investigating a novel stem cell therapy, known as SB623, that may hold the key to improving motor function following a disabling stroke.

Northwestern is currently one of only three sites in the nation enrolling participants in a landmark study to test the safety and efficacy of adult stem cell therapy for patients with stable ischemic stroke. Accounting for 87 percent of strokes, ischemic stroke occurs when a blocked artery interrupts the flow of oxygen and blood to the brain. This causes cell death and brain damage which can leave a person with impaired body functions, including paralysis, weakness on one side, difficulty with speech and language, vision issues, and cognitive challenges.

"Two million brain cells die each minute during a stroke making it critical to get treatment fast at the earliest sign of symptoms; once brain damage occurs, there's very little that can be done medically to reverse it," said principal investigator Joshua Rosenow, MD, director of Functional Neurosurgery at Northwestern Memorial Hospital and associate professor of neurosurgery, neurology, and physical medicine and rehabilitation at Northwestern University Feinberg School of Medicine. "While this study is only a preliminary step towards understanding the healing potential of these cells, we are excited about what a successful trial could do for a patient population that currently has very limited therapeutic options."

While the study's primary purpose is to examine the safety of SB623 stem cells, researchers will also seek to determine if the cells are effective in improving stroke symptoms. SB623 is derived from genetically engineered adult bone marrow cells from a healthy adult donor.

"Although not proven in humans, these stem cells have been shown to promote healing and improve function when administered in animal models of stable stroke," said co-investigator Richard Bernstein, MD, director of Northwestern Memorial's Stroke Center and associate professor of neurology at the Feinberg School. "The cells did not replace the neurons destroyed by stroke, but instead they appeared to encourage the brain to heal itself and promote the body's natural regenerative process. Eventually, the implanted stem cells disappeared."

"In this study, the cells are transplanted into the brain using brain mapping technology and scans, allowing us to precisely deposit the cells in the brain adjacent to the area damaged by stroke," explained Rosenow.

Early participants have received 2.5 million cells, but as the study progresses the dose will escalate to 5 million and eventually 10 million cells. Since SB623 cells are allogeneic, a single donor's cells can be used to treat many other individuals. Participants in the study will be followed for up to two years with periodic evaluations for safety and effectiveness in the improvement in motor function.

"Stroke can be a very disabling and life changing event," said Bernstein. "Even just a slight improvement in function could make a huge difference for a person impacted by stroke. To potentially give our patients the opportunity to permanently regain movement or speech is a very exciting prospect. In the animal models, the improvements appeared to remain even after the implanted stem cells disappeared."

Read more here:
Northwestern Medicine researchers investigate stem cell therapy for stroke

Genetic engineering of Pyrococcus furiosus to use chitin as a carbon source 7thSpace Interactive (press release) Bioinformatic analysis of the genes coding for the chitinase in Pyrococcus furiosus and Thermococcus kodakarensis revealed that most likely a one nucleotide insertion in Pyrococcus caused a frame shift in the chitinase gene. This splits the enzyme into ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNF9hKrynljz4W874WMYN2WxlWtfXg&url=http://7thspace.com/headlines/431995/genetic_engineering_of_pyrococcus_furiosus_to_use_chitin_as_a_carbon_source.html

FoodNavigator.com

Genetic engineering: It's a technology, not an ideology FoodNavigator.com Genetic engineering shouldn't be a political issue, no matter how much sci-fi-sensitive individuals might be reminded of the plot from The Day of the Triffids. Plants can be engineered in many ways, and their potential benefits should be balanced with ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFGrHM9GOTcq0VWQ1NVtNFp4bro0w&url=http://www.foodnavigator.com/Science-Nutrition/Genetic-engineering-It-s-a-technology-not-an-ideology

SunLive (blog)

The hidden costs of genetic engineering SunLive (blog) Genetically engineered pollen that blows across the road is perfectly happy to mate with the flowers that live there. If you grow from genetically engineered seed, your crop is patented and you do not own it. You are simply licensed to grow and sell it ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEExjO1gdrf9NdzTw17gLTRJJ381Q&url=http://www.sunlive.co.nz/blogs/4129-the-hidden-costs-of-genetic-engineering.html

Angel Biotechnology firm on the brink Edinburgh Evening News Penicuik-based Angel Biotechnology said it had been forced to take the step after talks with an overseas consortium over a strategic partnership broke down. Administrators at KPMG said they were assessing Angel's finances with a view to finding a buyer. Angel Biotechnology falls into administrationScotsman Angel Biotechnology to call in administratorsBusiness7 ANGEL BIOTECHNOLOGY HOLDINGS PLC : Statement re. Suspension4-traders (press release) nebusiness.co.uk -Herald Scotland -ShareCast all 7 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHNbVcrCIL5zcGNAfbWVAsisa2tZQ&url=http://www.scotsman.com/edinburgh-evening-news/latest-news/angel-biotechnology-firm-on-the-brink-1-2783013

Biotechnology finishing school to train second batch Times of India LUCKNOW: A biotech park has introduced a biotechnology finishing school to help students who pass out with a degree in BTech, MSc and other disciplines of life sciences but are not equipped with skills needed by the industry and advance institutes of ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHOzra46CIRiB8lwXCQxILIQpb_SA&url=http://timesofindia.indiatimes.com/city/lucknow/Biotechnology-finishing-school-to-train-second-batch/articleshow/18403312.cms

Oregon Natural Resources Report

Environmentalist has change of heart about biotechnology Western Farm Press Mark Lynas says his opinion on biotech crops was changed because he became familiar with scientific literature and realized he had never done any academic research on biotechnology – despite being a fervent opponent against it for years. Top environmentalist converts on GMOOregon Natural Resources Report GM-food activist switches sides of the debateVancouver Sun all 3 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEeC7Qd8oaV9YGJ0rkdgRGaeTWx8w&url=http://westernfarmpress.com/government/environmentalist-has-change-heart-about-biotechnology

Myjoyonline.com

Forum engages media on biotechnology for food productivity Myjoyonline.com By working closely with scientists and policy makers, the media should define an African agenda for biotechnology or else the continent will forever be dependent on food aid from countries that have adopted innovative agricultural technologies to ... Africa urged to use biotechnology to address food insecurityGhana Business News all 2 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHgvSmRxd5EuxVgV5YO7OBCWZUJ6Q&url=http://business.myjoyonline.com/pages/news/201302/101077.php

BioTime acquires Geron's stem cell program Nature.com Nature Biotechnology. Full text access provided to Googlebot Access by Web Services. Search Go Advanced search · nature.com · journal home · current issue · News; full text. Nature Biotechnology | News. Print; Email; Share/bookmark. Cite U Like ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE8_RlBlaucJ3SZlnjihxY1e211Rw&url=http://www.nature.com/nbt/journal/v31/n2/full/nbt0213-94a.html

Cuba - Investing In Biotechnology To Battle Cancer Medical News Today Dr. Augstin Lage Davila, General Director of the Center of Molecular Immunology (CIM), said "Biotechnology is key to transforming cancer from a deadly disease into a chronic one. Our drugs make chemo and radiation therapies more effective and less toxic. Cuba on the way to turning cancer into a chronic diseasePravda all 4 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNF9rTW7qHXwQIytEQbF2HunbSo3XQ&url=http://www.medicalnewstoday.com/articles/255830.php

A member of the governing board of the
California stem cell agency is taking exception to a statement on the
California Stem Cell Report that no independent members sit on that
body.

“I have to object to this line: 'None
of the current members are independent. The ballot measure that
created the agency required board members to be appointed from
various constituencies.' 

“I think I am absolutely independent,
and I think the same applies at the very least to most if not all of
my fellow patient advocates, and probably to the biotech
representatives as well – remember that they all must come from
companies that are not involved in stem cell research.  Although
I supported the proposition, I was not involved directly in the
campaign in any way, and I did not meet Bob Klein (the first chairman of the stem cell board) or any of my fellow
board members until the day I was sworn in at our first meeting.

“The Prop. 71 language I believe
specifies that advocates must have a record of advocating for people
with the disease or diseases they represent, and not that they belong
to or work for any specific organization.  Checking my binder,
it refers to 'groups' but does not specify those – for example, it
refers to 'representative of a California regional, state or national
HIV/AIDS disease advocacy group.' I’m not sure how you would
define 'independent' but I certainly don’t think it means
'disinterested.'”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/1YDDznoTw4E/stem-cell-agency-board-member-defends.html

The California stem cell agency's
attempts to deal with the conflict of interest problems at the $3
billion research program amount to a minor fix that is not a “serious solution,” the Riverside Press-Enterprise editorialized yesterday.

“That arrangement is hardly a model
of objective decision making. The agency so far has distributed about
$1.7 billion in grants, with about 90 percent of that money going to
institutions represented on the governing board. 

“Voluntary abstentions are not a
serious solution to that ethical minefield. Nor would that approach
eliminate potential conflicts, because the agency would still allow
the abstaining members to take part in the discussions and debate
about who should get the grants. 

“The Institute of Medicine instead
recommended remaking the board with truly independent members who
have no stake in grant awards. The stem-cell agency rejected that
step because it would require changing Prop. 71, either through a
super-majority in the Legislature or another ballot measure. That
excuse should be a vivid warning to Californians about the dangers of
passing complex, costly and inflexible initiatives. 

“Agencies handling billions of
taxpayers’ dollars should not avoid good government practice or
basic fiscal safeguards. The stem-cell institute offers minor fixes
when it needs substantial changes — and legislators should not
accept that cavalier approach.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/VQ9QZ0E814c/riverside-newspaper-ethical-minefield.html

In the wake of recent considerable
criticism concerning conflicts of interest at the $3 billion California stem
cell agency, its leaders have taken to saying “no actual conflicts”
have been found at the agency.

“Our committee was given a set of
defined tasks from the IOM(which was under a $700,000 contract with
CIRM), and we followed them."

“(Board) members must represent
unconflicted loyalty to the interest of the foundation. This
accountability supersedes any conflicting loyalty such as that to
advocacy or interest groups, business interests, personal interests or paid or volunteer service
to other organizations.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/lRsZniTbXbU/debunking-stem-cell-agency-claims-of-no.html

Skin stem cells hold promise for burn patients
Vincent Gabriel, MD Jeff Biernaskie, PhD Recipients of Alberta Innovates - Health Solutions Collaborative Research Innovation Opportunities program

By: AIHSChannel

Read the rest here:
Skin stem cells hold promise for burn patients - Video

Stem Cell Therapy Webinar with Dr. Kamau Kokayi at Patients Medical
Join us as Dr. Kamau Kokayi, Director of Cell Technologies at the New York Stem Cell Treatment Center at Patients Medical in NYC explains what Adipose Derived Stem Cell Therapy is and what types of medical conditions Dr. Kokayi and his team of researchers are enrolling for the clinical trial.

By: PatientsMedicalNYC1

Read the original post:
Stem Cell Therapy Webinar with Dr. Kamau Kokayi at Patients Medical - Video

Stem Cell Therapy Testimonial - Arthritis Treatment (full version)
Stem Cell Therapy Testimonial - Arthritis Treatment (full version) 1-888-545-4333

By: Bofitmiami

View post:
Stem Cell Therapy Testimonial - Arthritis Treatment (full version) - Video